Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Exor takes 10% stake in data provider Clarivate, can rise to 17.5%

Published 03/04/2024, 08:47 AM
Updated 03/04/2024, 09:57 AM
© Reuters. FILE PHOTO: Exor logo is displayed in this illustration taken September 5, 2022. REUTERS/Dado Ruvic/Illustration/FILE PHOTO

MILAN (Reuters) -Italy's Agnelli family has a 10.1% stake in New York-listed information services provider Clarivate through their investment arm Exor (AS:EXOR), the two companies said on Monday, adding that Exor could increase its stake to up to 17.5%.

Exor controls companies including Ferrari (NYSE:RACE), agriculture and construction machine maker CNH and Serie A soccer club Juventus JUVE.MI, and is the single largest shareholder in automaker Stellantis (NYSE:STLA).

Monday's announcement is the latest step in the holding company's investment campaign, propelled two years ago by the $9 billion it raised from the sale of its reinsurer PartnerRe to France's Covea. It is using the cash for M&A and share buybacks.

"Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the company's management and board," the companies said.

As part of the agreement, Exor COO Suzanne Heywood would be a candidate for a seat on Clarivate's board at the company's shareholders meeting in May, they added.

Financial details were not disclosed, but UK-based Clarivate -- a global provider of data, analytics, technology and expert services to several sectors including healthcare -- has a market capitalisation of around $4.8 billions.

Exor, which already held a stake in Clarivate of just above 1%, has now become its second largest investor. Should it increase its shareholding to 17.5%, Exor would match the company's current top shareholder, private equity firm Leonard Green & Partners.

Exor's investments cover a broad range of industries, including manufacturing, healthcare, media, fashion, sport and technology. Last year the Netherlands-based company spent 2.6 billion euros to buy a 15% stake in Philips's and become its single largest investor.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.